Company intelligence / Profile preview

Senores Pharmaceuticals

Buford, Georgia, United States

Ownership: Private
Employees: ~158
Development stage: Other

Overview

Senores Pharmaceuticals has over 60 ANDA approvals in the US and commercializes more than 300 products worldwide, with specialty in complex and niche generics. The company recently acquired ANDAs for several cardiovascular and neurology drugs, expanding its U.S. pipeline and product breadth. Clinical results are consistent with generic benchmarks and the company regularly enjoys significant market share in its targeted products.[4][5][6][1][10]

Therapeutic areas: NeurologyPsychiatryCardiovascular
Modalities: Small moleculeOther Small moleculeGeneric drug
Industry: Biotech

Drug pipeline

1 asset

Optalidon

Discontinued

Partnerships

PrascoLannettJubilant Cadista PharmaceuticalsAlkem LaboratoriesSun Pharmaceuticals IndustriesDr. Reddy's LaboratoriesCipla USA

Beyond the preview

Go deeper on Senores Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senores Pharmaceuticals.

Explore the full profile